Cardiac remodeling as a consequence and cause of progressive heart failure

Clinical Cardiology

Volumn 21, Issue 12 SUPPL. 1, 1998, Pages

  Kurrelmeyer, Karla ^a   Kalra, Dinesh ^a   Bozkurt, Biykem ^a   Wang, Feng ^a   Dibbs, Ziad ^a   Seta, Yukihiro ^a   Baumgarten, George ^a   Engle, David ^a   Sivasubramanian, Natarajan ^a   Mann, Douglas L ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Cardiac myocyte; Heat failure; Left ventricular remodeling; Necrosis

Indexed keywords

APOPTOSIS; CELL DEATH; CONFERENCE PAPER; DOPPLER ECHOGRAPHY; HEART AFTERLOAD; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HUMAN; OXYGEN CONSUMPTION;

EID: 0031728743     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960211304     Document Type: Conference Paper

References (40)

1. Leiden JM: The genetics of dilated cardiomyopathy: Emerging clues to the puzzle. N Engl J Med 1997;337:1080-1081
2. Cohn JN: Structural basis for heart failure: Ventricular remodeling and its pharmacological inhibition. Circulation 1995;91:2504-2507
3. Douglas PS, Morrow R, Ioli A, Reicheck N: Left ventricular shape, afterload, and survival in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1989;13:311-315
4. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Levy D: Left ventricular dilation and the risk of congestive heart failure in people without myocardial infarction. N Engl Med 1997;336:1350-1355
5. Linzbach AJ: Heart failure from the point of view of quantitative anatomy. Am J Cardiol 1960;March:370-382
6. Lowes BD, Minobe W, Abraham WT, Rizeq MN, Bohimeyer TJ, Quaife RA, Roden RL, Dutcher DL, Robertson AD, Voelkel NF, Badesch DB, Groves BM, Gilbert EM, Bristow MR: Changes in gene expression in the intact human heart: Downregulation of α-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest 1997;100:2315-2324
7. Schaper J, Froede R, Hein S, Buck A, Hashizume H, Speiser B, Friedl A, Bleese N: Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation 1991;83:504-514
8. Beuckelmann DJ, Nabauer M, Erdmann E: Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation 1992;85:1046-1055
9. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB: Decreased catecholamine sensitivity and β-adrenergic-receptor density infailing human hearts. N Engl J Med 1982;307:205-211
10. Davies CH, Davia K, Bennett JG, Pepper JR, Poole-Wilson PA, Harding SE: Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation 1995;92:2540-2549
11. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBiano R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, Mallis GI, Sollano JA, Shannon J, Tandon PK, DeMets DL: Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 1991;325:1468-1475
12. The Pimobendan in Congestive Heart Failure (PICO) Investigators: Effect of pimobendan on exercise capacity in patients with heart failure: Main results from the pimobendan in congestive heart failure (PICO) trial. Heart 1996;76:223-231
13. Tsutsui H, Spinale FG, Nagatsu M, Schmid PG, Ishmara K, DeFreyte G, Cooper G, IV, Carabello BA: Effects of chronic β-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation. J Clin Invest 1994; 93:2639-2648
14. Hall SA, Cigarroa CG, Marcoux L, Risser RC, Grayburn PA, Eichhorn EJ: Time course of improvement in left venticular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol 1995; 25:1154-1161
15. Dipla K, Mattiello JA, Jeevanandam V, Houser SR, Margulies KB: Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation 1998;97:2316-2322
16. Josue O: Hypertrophie cardiaque causée par l'adrenaline et la toxine typhique. C R Soc Biol (Paris) 1907;63:285-290
17. Mann DL, Kent RL, Parsons B, Cooper G IV: Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 1992;85:790-804
18. Tan LB, Jalil JE, Pick R, Jarucki JS, Weber KT: Cardiac myocyte necrosis induced by angiotensin II. Circ Res 1991;69:1185-1195
19. Missov E, Calzolari C, Pau B: Circulating cardiac troponin I in severe congestive heart failure. Circulation 1997;96:2953-2958
20. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw B-A: Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996;335: 1182-1189
21. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P: Apoptosis in the failing human heart. N Engl J Med 1997;336:1131-1141
22. Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, Hintze TH, Olivetti G, Anversa P: Stretch-induced programmed myocyte cell death. J Clin Invest 1995;96:2247-2259
23. Leri A, Claudio PP, Li Q, Wang X, Reiss K, Wang S, Malhotra A, Kajstura J, Anversa P: Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p531 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest 1998;101:1326-1342
24. Krown KA, Page MT, Nguyen C, Zechner D, Gutierrez V, Comstock KL, Glembotski CC, Quintana PJE, Sabbadini, RA: Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes: Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 1996;98:2854-2865
25. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Sonnenblick EH, Olivetti G, Anversa P: The cellular basis of dilated cardiomyopathy in humans. Mol Cell Cardiol 1995;27: 291-305.
26. Jalil JE, Doering CW, Janicki JS, Pick R, Shroff SGS, Weber KT: Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 1989;64:1041-1050
27. Weber KT: Extracellular matrix remodeling in heart failure. A role for de novo angiotensin II generation. Circulation 1997;96: 4065-4082
28. Weber KT, Brilla CG, Janicki JS: Myocardial fibrosis: Functional significance and regulatory factors. Cardiovasc Res 1993;27: 341-348
29. Weber KT, Sun Y, Guarda E: Structural remodeling in hypertensive heart disease and the role of hormones. Hypertension 1994;23: 869-877
30. Weber KT: Cardiac intersitium in health and disease: The fibrillar collagen network. J Am Coll Cardiol 1989;13(7):1637-1652
31. Weber KT, Pick R, Janicki JS, Lakier JB: Inadequate collagen tethers in dilated cardiopathy. Am Heart J 1988;116:1641-1646
32. Thomas CV, Coker ML, Zellner JL, Handy JR, Crumbley JA III, Spinale FG: Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage heart failure. Circulation 1998;97:1708-1715
33. Tyagi SC, Kumar S, Voelker DJ, Reddy HK, Janicki JS, Curtis JJ: Differential gene expression of extracellular matrix components in dilated cardiomyopathy. J Cell Biochem 1996;63:185-198
34. Bozkurt B, Kribbs S, Clubb Jr, Michael LH, Didenko VV, Hornsby PJ, Seta Y, Oral H, Spinale FG, Mann DL: Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats. Circulation 1998;97:1382-1391
35. Ross J Jr: Afterload mismatch in aortic and mitral valve disease: Implications for surgical therapy. J Am Coll Cardiol 1985;5:811-826
36. Kono T, Sabbah HN, Rosman H, Alam M, Jafri S, Goldstein S: Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol 1992;20:1594-1598
37. Batista RJV, Santos JLV, Takeshita N, Bocchino L, Lima PN, Cunha MA: Partial left ventriculectomy to improve left ventricular function in end-stage heart disease. J Cardiol Surg 1996;11:96-97
38. Greenberg B, Quinones MA, Koilpillai C, Limacher M, Shindler D, Benedict CR, Shelton B: Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Circulation 1995;91:2573-2581
39. Sutton MSJ, Pfeffer MA, Plappert T, Rouleau J-L, Moyé LA, Dagenais GR, Lamar GA, Klein M, Sussex B, Goldman S, Menapace FJ Jr, Parker JO, Lewis S, Sestier F, Gordon DF, McEwan P, Bernstein V, Braunwald E: Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction: The protective effects of captopril. Circulation 1994;89:68-75
40. Doughty RN, Whalley GA, Gamble G, MacMahon S, Sharpe N: Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. J Am Coll Cardiol 1998;29:1060-1066